Unrelated donor hematopoietic stem cell transplantation for infantile enteropathy due to IL-10/IL-10 receptor defect

Pediatric Transplantation

Volumn 19, Issue 4, 2015, Pages E101-E103

  Gassas, Adam ^a   Courtney, Sarah ^a   Armstrong, Christine ^a   Kapllani, Erilda ^a   Muise, Aleixo M ^a,b   Schechter, Tal ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

allogeneic stem cell transplantation; IL 10 IL 10 receptor defect; unrelated donors

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; BUSULFAN; CYCLOSPORIN A; FLUDARABINE; GANCICLOVIR; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; METHOTREXATE; IL10 PROTEIN, HUMAN; IMMUNOSUPPRESSIVE AGENT;

ANTIBIOTIC THERAPY; ANUS FISSURE; ARTICLE; BLOOD SAMPLING; CASE REPORT; CHILD; CHILD DEATH; CHILDHOOD DISEASE; CHIMERA; COLITIS; CYTOMEGALOVIRUS INFECTION; DIARRHEA; END TO END ANASTOMOSIS; ENDOSCOPY; ENTEROPATHY; EXOME; FEMALE; FOLLICULITIS; FUNCTION TEST; GENE SEQUENCE; GENETIC DISORDER; GRAFT VERSUS HOST REACTION; HEALTH CARE QUALITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; ILEOSTOMY; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; INFLAMMATORY BOWEL DISEASE; LIVING DONOR; MEDICAL HISTORY; MOUTH ULCER; NECK INJURY; NEUTROPHIL; NEXT GENERATION SEQUENCING; NOSE FEEDING; PROTEIN DEFECT; RECTOVAGINAL FISTULA; RECURRENT DISEASE; REGISTER; RESPIRATORY TRACT DISEASE; SKIN DISEASE; THROMBOCYTE; TONGUE DISEASE; ALLOTRANSPLANTATION; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; GENETICS; IMMUNOLOGY; INFANT; INTERNATIONAL COOPERATION; MUTATION; PROCEDURES; STANDARDS; TRANSPLANTATION; TRANSPLANTATION CONDITIONING; UNRELATED DONORS;

DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INTERLEUKIN-10; INTERNATIONAL COOPERATION; INTESTINAL DISEASES; MUTATION; RECEPTORS, INTERLEUKIN-10; REGISTRIES; TISSUE AND ORGAN PROCUREMENT; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; UNRELATED DONORS;

EID: 84929049966     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12452     Document Type: Article

References (10)

1. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A,. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001: 19: 683-765.
2. Fiorentino DF, Zlotnik A, Vieira P, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991: 146: 3444-3451.
3. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W,. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993: 75: 263-274.
4. Begue B, Verdier J, Rieux-Laucat F, et al. Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease. Am J Gastroenterol 2011: 106: 1544-1555.
5. Kotlarz D, Beier R, Murugan D, et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease implications for diagnosis and therapy. Gastroenterology 2012: 143: 347-355.
6. Moran CJ, Walters TD, Guo CH, et al. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm Bowel Dis 2013: 115-123.
7. Glocker EO, Frede N, Perro M, et al. Infant colitis-it's in the genes. Lancet 2010: 376: 1272.
8. Glocker EO, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009: 361: 2033-2045.
9. Engelhardt KR, Shah N, Faizura-Yeop I, et al. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol 2013: 131: 825-830.
10. Murugan D, Albert MH, Langemeier J, et al. Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantation. J Clin Immunol 2014: 34: 331-339.